The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

ChatGPT may be clinically useful in providing patients with useful information regarding colon cancer, potentially complementing medical education efforts. Artificial intelligence (AI) systems ...

A clinical social worker describes how the application of positive psychology interventions may improve well-being and ...

The researchers found that imlunestrant prolonged progression-free survival (PFS) when compared to standard care in patients with ESR1 mutations, but there was no PFS benefit observed in the overall ...

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD. A rare case of diffuse large B-cell lymphoma (DLBCL) accompanied by ...

Researchers sought to determine trends and future patterns for liver, pancreatic, colorectal, stomach, and esophageal cancers in the US.

The instruments that were the most comprehensive and considered all 4 components [of resilience] were the 25-item CD-RISC, the Chinese version of the 25-item CD-RISC, and the Bharathiar University ...

T-DM1 sustained the improvement in invasive disease-free survival over trastuzumab in HER2-positive early breast cancer.

Researchers found that, in the most recent decade evaluated, the incidence of early-onset colorectal cancer increased in 27 countries and territories.